Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 X CD3 Bispecific Dart (R) Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia - Aix-Marseille Université Access content directly
Journal Articles Blood Year : 2018

Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 X CD3 Bispecific Dart (R) Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia

Sergio Rutella
  • Function : Author
Sarah E. Church
  • Function : Author
Jayakumar Vadakekolathu
  • Function : Author
Elena Viboch
  • Function : Author
Amy H. Sullivan
  • Function : Author
Tressa Hood
  • Function : Author
Sarah E. Warren
  • Function : Author
Alessandra Cesano
  • Function : Author
Ross La Motte-Mohs
  • Function : Author
John Muth
  • Function : Author
Bob Lowenberg
  • Function : Author
John F. Dipersio
  • Function : Author
Jan K. Davidson-Moncada
  • Function : Author

Dates and versions

hal-02143595 , version 1 (29-05-2019)

Identifiers

Cite

Sergio Rutella, Sarah E. Church, Jayakumar Vadakekolathu, Elena Viboch, Amy H. Sullivan, et al.. Adaptive Immune Gene Signatures Correlate with Response to Flotetuzumab, a CD123 X CD3 Bispecific Dart (R) Molecule, in Patients with Relapsed/Refractory Acute Myeloid Leukemia. Blood, 2018, 132 (1), ⟨10.1182/blood-2018-99-111539⟩. ⟨hal-02143595⟩

Collections

CNRS UNIV-AMU CRCM
18 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More